Watch CBS News

AstraZeneca

cbsn-fusion-us-vaccination-slowdown-biden-july-4-deadline-analysis-brianna-abbott-thumbnail-730397-640x360.jpg

U.S. COVID vaccinations slowing ahead of July 4 deadline

According to the CDC, more than 63% of Americans have their first dose of the COVID vaccination. But, an analysis by The Washington Post found that the country is now averaging fewer than 1 million shots per day. Health experts are concerned this slowdown might hinder the Biden administration's goal of having 70% of Americans with one vaccination by July 4. Brianna Abbott, health reporter for The Wall Street Journal, joins CBSN's "Red & Blue" to discuss.

cbsn-fusion-blood-clots-more-likely-in-people-with-covid-19-infections-than-vaccines-study-shows-thumbnail-693542-640x360.jpg

New study may shed light on COVID blood clots

Research from Oxford University in England has new data regarding the rate of blood clotting cases in COVID-19 patients and vaccine recipients. The study, which has not been peer-reviewed yet, shows that the particular blood clot which was studied is eight to ten times more common in people who experience a COVID-19 infection than in people who were inoculated. Dr. David Agus joins "CBS This Morning" to explain the latest development.

cbsn-fusion-covid-19-hotspots-states-michigan-florida-pennsylvania-new-york-thumbnail-687444-640x360.jpg

5 states are COVID-19 hotspots

The U.S. vaccination program is moving quickly, but health officials are concerned about rapidly spreading variants of the coronavirus. Politico health care reporter Alice Miranda Ollstein joins "Red and Blue" anchor Elaine Quijano with more on how the government is addressing a surge of new cases in five hotspots, a possible link between AstraZeneca's vaccine (which is not being used in the U.S.) and blood clots, and the challenges involved in contact tracing.

0325-cbsn-tcd-677145-640x360.jpg

Doctor on new AstraZeneca vaccine data

After U.S. health officials called out AstraZeneca for using "outdated information" in its vaccine trial results, the drugmaker has released updated data showing its vaccine is 76% effective against symptomatic COVID-19. Dr. Leo Nissola spoke with Anne-Marie Green and Vladimir Duthiers on CBSN about whether the change is significant, plus he discusses a study that found U.S. media coverage of the pandemic is more negative than other countries'.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.